Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

VKTXVKTX
7 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in VIKING THERAPEUTICS INC

JPMORGAN CHASE & CO holds 915,185 shares of VKTX (VIKING THERAPEUTICS INC), worth $36.4M as of 2026-Q2. The position was increased (+88.4% shares). VKTX represents 0.0% of JPMORGAN CHASE & CO's portfolio.

Current Value

$36.4M

Current Shares

915,185

Total Value Change

-$50.4M

Total Shares Change

-1.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
915,185
+88.4%
$36.4M0.0%$39.01
45
2026-Q1
Decreased
485,703
-11.2%
$14.5M0.0%$31.93
0
2025-Q4
Decreased
546,828
-89.4%
$19.2M0.0%$35.32
0
2025-Q3
Increased
5.2M
+95.3%
$135.5M0.0%$25.81
48
2025-Q2
Decreased
2.6M
-15.6%
$69.9M0.0%$26.52
0
2025-Q1
Increased
3.1M
+44.9%
$75.5M0.0%$25.65
40
2024-Q4
New
2.2M
-
$86.8M0.0%$39.77
41

Other major holders of VKTX: BlackRock Finance, Inc., FMR LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used